Insider Trading: Dendreon Corp (DNDN.O)

DNDN.O on Nasdaq

3.89USD
24 May 2013
Price Change (% chg)

$-0.02 (-0.51%)
Prev Close
$3.91
Open
$3.92
Day's High
$3.93
Day's Low
$3.86
Volume
2,058,242
Avg. Vol
4,456,860
52-wk High
$7.94
52-wk Low
$3.69

Search Stocks
BAYH SUSAN B
Trading Date Type Shares Traded Price Shares Held
2 Jan 2013 Buy 25,000 $0.00 90,757
2 Jan 2012 Buy 25,000 $0.00 65,757
8 Sep 2011 Buy 20,000 $11.05 40,757
Previous Page 1 of 1

Institutional Holders

% Shares Owned: 59.67%
# of Holders: 213
Total Shares Held: 94,042,015
3 Mo. Net Change: -2,430,635
# New Positions: 30
# Closed Positions: 34
# Increased Positions: 79
# Reduced Positions: 95
# Net Buyers: -16

Officers & Directors

Name Age Since Current Position

John Johnson

 55 2012 Chairman of the Board, President, Chief Executive Officer

Gregory Schiffman

 56 2010 Chief Financial Officer, Executive Vice President, Treasurer

Christine Cvijic

 35 2012 Executive Vice President - Corporate Development, General Counsel, Secretary

Gregory Mayes

 44 2013 Executive Vice President - Human Resources

Joseph DePinto

 45 2012 Executive Vice President - Commercial Operations

Mark Frohlich

 51 2011 Executive Vice President - Research and Development and Chief Medical Officer

William Monteith

 55 2013 Executive Vice President - Technical Operations

Lindsay Rocco

 34 2012 Executive Vice President - Corporate Communications

Douglas Watson

 68 2012 Lead Independent Director

David Urdal

 63 2011 Director

Susan Bayh

 53 2003 Independent Director

Bogdan Dziurzynski

 64 2001 Independent Director

Dennis Fenton

 61 2011 Independent Director

Pedro Granadillo

 65 2009 Independent Director

David Stump

 63 2010 Independent Director
Search Stocks